Lista de obras - Malte von Bonin - Dominio Público Uruguay

A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells

artículo científico publicado en 2014

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

artículo científico publicado en 2010

A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche

artículo científico publicado en 2017

Abstracts of the 52nd Workshop for Pediatric Research : Frankfurt, Germany. 27-28 October 2016.

artículo científico publicado en 2017

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

artículo científico publicado en 2015

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

artículo científico publicado en 2015

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

artículo científico publicado en 2022

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

artículo científico publicado en 2014

Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial

artículo científico publicado en 2018

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

artículo científico publicado en 2017

Breast cancer cells compete with hematopoietic stem and progenitor cells for intercellular adhesion molecule 1-mediated binding to the bone marrow microenvironment

artículo científico publicado en 2016

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia

publication published on 15 April 2021

Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.

artículo científico publicado en 2017

Concise review: the bone marrow niche as a target of graft versus host disease

artículo científico publicado en 2014

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor

artículo científico publicado en 2018

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

artículo científico publicado en 2020

Dynamics of epigenetic age following hematopoietic stem cell transplantation

artículo científico publicado en 2017

Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib

artículo científico publicado en 2005

Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial

scientific article published on 05 April 2018

Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.

artículo científico publicado en 2016

Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology

artículo científico publicado en 2016

Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses

artículo científico publicado en 2012

Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial

artículo científico publicado en 2009

Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice.

artículo científico publicado en 2018

Hip pain in medulloblastoma as first symptom of extraneural relapse.

artículo científico publicado en 2011

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2017

In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice

artículo científico publicado en 2013

Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients

scientific article published on September 2008

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter

artículo científico publicado en 2018

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

artículo científico publicado en 2017

Long-Term Mixed Chimerism After <i>Ex Vivo</i>/<i>In Vivo</i> T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

artículo científico publicado en 2021

Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system

artículo científico publicado en 2011

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation

artículo científico publicado en 2012

Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).

artículo científico publicado en 2016

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

artículo científico publicado en 2018

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

artículo científico publicado en 2015

Neurotrophin Receptor p75NTR Regulates Immune Function of Plasmacytoid Dendritic Cells

artículo científico publicado en 2017

Peptidyl prolyl / isomerase activity on the cell surface correlates with extracellular matrix development

artículo científico publicado en 2019

Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.

artículo científico publicado en 2003

Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.

artículo científico publicado en 2018

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug

artículo científico publicado en 2015

Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2019

Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells

artículo científico publicado en 2017

Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML.

artículo científico publicado en 2009

STK3 is a therapeutic target for a subset of acute myeloid leukemias.

artículo científico publicado en 2018

Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche.

artículo científico publicado en 2017

Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.

artículo científico publicado en 2016

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

artículo científico publicado en 2009

TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity

artículo científico publicado en 2013

Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation

artículo científico publicado en 2009

Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

artículo científico publicado en 2008

Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module

artículo científico publicado en 2011

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells

artículo científico publicado en 2017

Lista de obras de Malte von Bonin

A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche

Abstracts of the 52nd Workshop for Pediatric Research : Frankfurt, Germany. 27-28 October 2016.

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

Breast cancer cells compete with hematopoietic stem and progenitor cells for intercellular adhesion molecule 1-mediated binding to the bone marrow microenvironment

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia

Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.

Concise review: the bone marrow niche as a target of graft versus host disease

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Dynamics of epigenetic age following hematopoietic stem cell transplantation

Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib

Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial

Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.

Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology

Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses

Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial

Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice.

Hip pain in medulloblastoma as first symptom of extraneural relapse.

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice

Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

Long-Term Mixed Chimerism After <i>Ex Vivo</i>/<i>In Vivo</i> T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation

Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

Neurotrophin Receptor p75NTR Regulates Immune Function of Plasmacytoid Dendritic Cells

Peptidyl prolyl / isomerase activity on the cell surface correlates with extracellular matrix development

Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.

Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug

Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation

Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells

Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML.

STK3 is a therapeutic target for a subset of acute myeloid leukemias.

Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche.

Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity

Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation

Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells